Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation

Methods in Molecular Biology

Volumn 1393, Issue , 2016, Pages 141-145

  Ruggeri, Loredana ^a   Mancusi, Antonella ^a   Urbani, Elena ^a   Velardi, Andrea ^a  

^a NONE

Author keywords

HLA haplotype mismatched hematopoietic transplantation; KIR genotyping; KIR phenotyping; NK cell alloreactivity; NK cells

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; IMMUNOGLOBULIN G1; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; PHYTOHEMAGGLUTININ; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KIR3DL1 PROTEIN, HUMAN;

ALLOIMMUNITY; CYTOTOXICITY ASSAY; EVENT FREE SURVIVAL; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; RECURRENCE RISK; DONOR; GENETICS; GENOTYPING TECHNIQUE; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; PROCEDURES;

GENOTYPING TECHNIQUES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, KIR3DL1; TISSUE DONORS;

EID: 84962768875     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3338-9_14     Document Type: Chapter

References (11)

1. Ruggeri L, Capanni M, Urbani E et al (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-20100
2. Ruggeri L, Capanni M, Casucci M et al (1999) Role of natural killer cell alloreactivity in HLAmismatched hematopoietic stem cell transplantation. Blood 94:333-339
3. Pende D, Marcenaro S, Falco M et al (2009) Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113: 3119-3129
4. Willemze R et al (2009) KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 23:492-500
5. Ciccone E, Pende D, Viale O et al (1992) Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med 175:709-718
6. Colonna M, Brooks EG, Falco M et al (1993) Generation of allospecific natural killer cells by stimulation across a polymorphism of HLAC. Science 260:1121-1124
7. Foley BA, De Santis D, Van Beelen E et al (2008) The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood 112:435-443
8. Velardi A (2008) Role of KIRs and KIR ligands in hematopoietic transplantation. Curr Opin Immunol 20:581-587
9. Velardi A, Ruggeri L, Mancusi A et al (2009) Natural killer cell allorecognition of missing self in allogeneic hematopoietic t ransplantation: a tool for immunotherapy of leukemia. Curr Opin Immunol 21:525-530
10. Foley B, De Santis D, Lathbury L et al (2008) KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol 20:555-563
11. Chewning JH, Gudme CN, Hsu KC et al (2007) KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 179:854-868